एंटिकोगुलेशन इसके अंग्रेजी अर्थ का उदाहरण

Iliopsoas muscle is a common site of bleeding in patients who are undergoing blood anticoagulation.

Contrary to valve replacement with mechanical prostheses inhibition of the blood clotting system (anticoagulation) is not necessary after aortic valve repair.

Compared to the results of valve replacement there will be a minimal tendency towards clot formation after aortic valve repair, and anticoagulation is commonly not necessary, thus minimizing the possibility of bleeding complications.

It allows predictable anticoagulation and dose adjustments and routine coagulation monitoring; dietary restrictions are not needed.

A heparinase TEG is used to assess for heparin-associated anticoagulation as the cause of hemorrhage.

Clotting problems can occur for which anticoagulation may be needed.

Typical complications are blood clot formation on the valve or dislodgment of thrombus (embolism); bleeding complications are commonly a consequence of “blood-thinning” medication needed to prevent clots (anticoagulation).

Salt-restriction, diuretics, angiotensin-converting enzyme inhibitors, and anticoagulation may be indicated for managing restrictive cardiomyopathy.

Once these are exhausted or the use of therapeutic anticoagulation is contraindicated (for example, in a cooccurring traumatic hemorrhage), mechanical thrombectomy may be used to physically remove the embolism from the blocked artery.

Unless there are underlying reasons why it would be harmful, anticoagulation (low molecular weight heparin, followed by warfarin) is often initiated and maintained in patients who do not have cirrhosis.

The traditional treatment for thrombosis is the same as for a lower extremity DVT, and involves systemic anticoagulation to prevent a pulmonary embolus.

Therapeutic preventional anticoagulation is first line, if correction of the underlying anatomical pathology is not already done, by using Heparin or other anticoagulative agents.

एंटिकोगुलेशन हिंदी उपयोग और उदाहरण

"" यह आंकड़ा, 1960 में बैरिट और जॉर्डन द्वारा प्रकाशित एक परीक्षण का है, जो पीई के प्रबंधन के लिए प्रायोगिक औषध के विरूद्ध एंटिकोगुलेशन की तुलना करता है।

रक्तस्राव के उच्च जोखिम वाले रोगियों में, डायलिसिस को एंटिकोगुलेशन के बिना किया जा सकता है।

एक बार एंटिकोगुलेशन के बंद होने पर है, घातक फुफ्फुसीय अन्त:शल्यता का जोखिम प्रति वर्ष 0.5% है।